Company: LIMN
Filing Date: 2025-07-17
Form Type: 8-K
Source: 0001104659-25-068670
Chunk: 0

Company: Liminatus Pharma, Inc.
Filing Date: 2025-07-17
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01 Entry into a Material Definitive
Agreement.

On July 16, 2025, Liminatus Pharma, Inc. (the
“ Company”) entered into a settlement and release agreement (the “ Settlement Agreement”) with Alta Partners, LLC
(the “ Holder”), pursuant to which the Company agreed to issue 350,000 shares (the “ Shares”) of its common stock,
par value $0.0001 per share (“ Common Stock”), to the Holder in exchange for the surrender and cancellation of 1,000,000 warrants
(the “ Warrants”) to purchase shares of Common Stock held by the Holder.

No commission or other remuneration was paid or
given, directly or indirectly, in connection with the exchange of the Warrants for the Shares.

Item 3.02 Unregistered Sales of Equity Securities.